| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0020200 | Intron-Intron | chr7:122427594-122430449 | chr7:122787540-122790395 | 2856 nt | 0.3999 |
| hsa_chr7_0100600 | Intergenic-Intergenic | chr7:122439739-122440134 | chr7:122799685-122800080 | 396 nt | 0.3510 |
| hsa_CADPS2_0020400 | Intron-Intron | chr7:122493955-122494417 | chr7:122853901-122854363 | 463 nt | 0.5400 |
| hsa_CADPS2_0020500 | Intron-Intron | chr7:122496303-122496506 | chr7:122856249-122856452 | 204 nt | 0.4069 |
| hsa_chr7_0100800 | Intergenic-Intergenic | chr7:122503763-122504019 | chr7:122863709-122863965 | 257 nt | 0.4786 |
| hsa_CADPS2_0020600 | Intron-Intron | chr7:122516297-122516522 | chr7:122876243-122876468 | 226 nt | 0.4469 |
| hsa_chr7_0100900 | Intergenic-Intergenic | chr7:122521838-122522048 | chr7:122881784-122881994 | 211 nt | 0.3791 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].